Analystreport

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was given a new $36.00 price target on by analysts at UBS Group AG.

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report